FindTrial
Sign In

Utility of a new imaging test to diagnose mold (fungus) infection in children with cancer who have reduced immunity

Diagnostic accuracy of antifungal scintigraphy in diagnosing invasive fungal disease (IFD) in febrile neutropenia in pediatric hematologic malignancies - RSIFD

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/03/032396
Enrollment
30
Registered
2021-03-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C910- Acute lymphoblastic leukemia [ALL] Health Condition 2: C920- Acute myeloblastic leukemia

Interventions

None listed

Sponsors

AIIMS New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children (less than 18 years) with hematological malignancy and FN (either post chemotherapy or after hematopoietic stem cell transplantation), who shows any abnormality on CECT scan; will be recruited after obtaining informed written consent.

Exclusion criteria

Exclusion criteria: 1. Solid malignancies after chemotherapy having neutropenia 2. Other causes of neutropenia 3. Patients who refused to give consent 4. Patients with impaired renal function (Serum Creatinine > 1.3 mg%) 5. Patients with a normal CECT scan

Design outcomes

Primary

MeasureTime frame
Diagnosis of invasive fungal infection on scintigraphyTimepoint: 12 months—

Secondary

MeasureTime frame
To define the extent of disease on scintigraphyTimepoint: 12 months—

Countries

India

Contacts

Public ContactMANISHA JANA

All India Institute of Medical Sciences New Delhi

manishajana@gmail.com09013590837

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026